Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology

Wei-Ting Lee1, Pei-Ying Wu1, Ya-Min Cheng1,2

  • 1Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.

International Journal of Molecular Sciences
|March 28, 2024
PubMed

Insights

Tissue inhibitor of metalloproteinases-3 (TIMP3) plays a crucial role in cancer, with decreased expression linked to increased tumor cell invasion. Its complex role in various cancers, especially gynecological ones, requires further elucidation for therapeutic targeting.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tissue inhibitor of metalloproteinases-3 (TIMP3) is a key regulator of biological processes, exhibiting both matrix metalloproteinase (MMP)-dependent and independent anti-tumor effects.
  • Reduced TIMP3 expression, often due to promoter methylation and miRNA binding, is observed in various cancers, correlating with increased cancer cell migration and invasion.
  • Conflicting reports exist regarding TIMP3 expression levels in cancerous versus healthy tissues, necessitating a clearer understanding of its role.

Purpose of the Study:

  • To review the biological functions of TIMP3.
  • To elucidate the multifaceted role of TIMP3 in cancer biology and progression.
  • To specifically detail TIMP3's involvement in gynecological cancers.

Main Methods:

  • Literature review of TIMP3's biological functions.
  • Analysis of TIMP3's impact on various cancer types.
  • Detailed examination of TIMP3 in gynecological malignancies.

Main Results:

  • TIMP3 demonstrates anti-tumor properties through MMP-dependent and independent mechanisms.
  • Decreased TIMP3 expression is associated with enhanced cancer cell migration and invasion.
  • TIMP3 is implicated in cervical adenocarcinoma, serous ovarian cancer, and breast cancer metastasis, though its role in endometrial cancer is unclear.

Conclusions:

  • TIMP3's complex role in cancer necessitates further investigation.
  • TIMP3 shows potential as a diagnostic biomarker for gynecological cancers.
  • TIMP3 represents a promising therapeutic target for future cancer treatments.
Keywords:
biomarkercancer therapygynaecological cancerstissue inhibitor of metalloproteinases-3

More Related Videos

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

7.4K
Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

4.5K

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K